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Pseudo-Pseudotumor: A Cautionary Tale
Brian Westerhuis and Sachin Kedar
Mentor: Sachin Kedar 
Program: Neurology
Background: Idiopathic Intracranial 
Hypertension (IIH) is a commonly considered 
diagnosis and common reason for neurology 
consultation.
Methodology: Case series
Results: Two cases of presumed IIH presented 
with progressively worsening headache and 
reduced vision. Both had papilledema on 
exam and elevated CSF opening pressures 
on lumbar puncture. CSF contents were 
normal. In one, initial imaging (MRI brain) 
revealed the “partially empty sella” raising 
concern for IIH. In the other, imaging was 
initially unrevealing. Both were started on 
Acetazolamide for presumed IIH. Both 
patients experienced progressive deterioration 
of vision, papilledema and headache. The 
first patient was found to have extensive 
cerebral venous sinus thrombosis and started 
on anticoagulation. The second patient was 
found to have leptomeningeal glioma after 
several months and started on chemotherapy. 
Guidelines and recommendations for 
evaluating these patients are reviewed
Conclusion: Numerous processes produce 
elevated intracranial pressure, including 
cerebral venous sinus thrombosis and 
intracranial malignancies. “Pseudotumor 
cerebri” remains a diagnosis of exclusion, 
particularly in patients who do not fit the 
“classic” phenotype. There is a very real 
danger in prematurely closing on the diagnosis 
without sufficient investigation to rule out 
other causes. A high index of suspicion for 
an alternate diagnosis must remain until 
sufficient investigation is completed.  
https://doi.org/10.32873/unmc.dc.gmerj.1.1.068
Evaluation of a Midline Catheter Program and Effect on Central Line Associated Blood Stream Infections
Richard Hankins, Mark Rupp, Teresa Micheels, Luana Evans, Angela Boesch, Kim Hayes, Adrienne Sy, Kelly Cawcutt
Mentor: Kelly Cawcutt 
Program: Infectious Disease
Background: Central line associated 
blood stream infections (CLABSI) result 
in increased patient morbidity. Guidelines 
recommend against peripheral venous 
catheters when access is required for longer 
than 6 days, leading to central venous catheter 
(CVCs) placement. To improve vascular 
access device choice, we implemented a 
quality improvement initiative compromised 
of a new vascular access algorithm with 
introduction of midline utilization and sought 
to evaluate the impact of midline use on 
CLABSI rates.
Methods: A prospective quality improvement 
assessment from October 2017 through 
March 2018 analyzed vascular access. When 
a consult was placed for a peripherally 
inserted central catheter (PICC) a patient 
would be evaluated via the vascular access 
algorithm for whether they should receive 
a midline catheter, a PICC or CVC. They 
were then monitored for duration of indwell 
and bloodstream infections consistent with 
reportable CLABSI definitions. 
Results: In the month prior to 
implementation, the institutional CLABSI 
rate was 1.36 per 1000 CVC (including PICC) 
days. Since October 2017, there have been 
4588 midline catheter days, with 2 midline 
infections, for a cumulative rate over 6 
months of 0.435 midline catheter infections 
per 1000 midline days. This was compared 
to 26,575 CVC days, with 33 documented 
CLABSIs, for a rate of 1.242 per 1000 CVC 
days. 
Conclusion: The implementation of a 
vascular access algorithm including midlines 
may reduce central line insertions and 
decrease CLABSIs through utilization of a 
lower risk device (midline). Further research 
into comparing additional risks and benefits 
of midline catheters and all styles of central 
venous catheters is warranted. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.069
Left Ventricular Assist Device (LVAD) Infections: A Single Center Experience
Rajendra Karnatak, Uriel Sadkovsky
Mentor: Uriel Sadkovsky 
Program: Infectious Disease
Background: Infectious complications play a 
major role in morbidity LVAD implantation. 
We report the incidence of LVAD infections at 
our institution over 1-year period. 
Methods: Retrospective review of 36 patients 
who had a continuous-flow LVAD implanted 
between Jan 1-Dec 31, 2013. Infectious 
complications were defined as per ISHLT 
standardized definition. Only patients with 
a new LVAD were included. Follow-up 
occurred until heart transplantation or death.
Results: All patients underwent Heartmate 
II implantation; 55% received the LVAD as 
bridge to transplantation. We identified 39 
episodes of infection in 20 (55%) patients. 
Mean age (±SD) 52±15 years. A total of 
19175 person-days of LVAD support was 
followed, and average duration of LVAD 
support was 533 days. There were 11 (25%) 
driveline infections, 9 (21%) bloodstream 
infections. The most common micro-
organism causing bloodstream infections 
were coagulase negative staphylococci 
4/9 (44%), followed by Staphylococcus 
aureus 2/9 (22%), Enterococci 1/9 (11%), 
Streptococci 1/9 (11%), and Candida 1/9 
(11%). Table 1 summarizes incidence of 
LVAD infections cases per 100-person years 
of LVAD support as per ISHLT definition. 
Two patients (6%) developed VAD-specific 
cannula/pump infections, one treated with 
Intravenous antibiotics followed by heart 
transplantation, and one required long-term 
antibiotic suppression. Cumulative all-cause 
mortality at two years follow up was 19%. 
Two-year cumulative all-cause mortality in 
patients with LVAD infections was lower than 
patients without infections 15% versus 25% 
(RR 0.6, 95% CI 0.15 to 2.3), respectively. 
There were 8 (22%) patients treated for 
an infection within 30 days prior to LVAD 
implantation, out of these 4 developed post 
LVAD infections, 4 did not develop infectious 
complications (20% vs 25% RR 0.8, 95% CI 
0.23 TO 2.7), respectively. The most common 
cause of death was withdrawal of support/
multi-organ failure, 4 patients (57%). Only 
1/7 (14.2%) deaths during two-year period 
were due to infectious complications. 
Conclusion: Morbidity in LVAD recipients is 
primarily driven by driveline infections and 
bacteremia. Infectious complications were not 
associated with increased mortality.  
https://doi.org/10.32873/unmc.dc.gmerj.1.1.070
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